Crossmark

Developmental strategy for swellable/erodible matrix tablet of mirabegron: quality by design approach with various geometric properties and pharmacokinetic evaluation

Crossref DOI link: https://doi.org/10.1007/s40005-023-00642-x

Published Online: 2023-11-21

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Ji Yeon

Kim, Tae Hwan

Kim, Eunbin

Choi, Du Hyung
License Information

Text and Data Mining valid from 2023-11-01

Version of Record valid from 2023-11-01
More Information

Article History

Received: 17 September 2023

Accepted: 25 October 2023

First Online: 21 November 2023

Declarations

:

: All authors (J.Y. Kim, T.H. Kim, E Kim, and D.H. Choi) declare no conflicts of interest.

: The animal experimental protocols were approved, and all animals received care in compliance with the guidelines of the Animal Care Committee of HLB BioStep Co., Ltd. (BIOSTEP IACUC 23-KE-0155).

Document is current

Any future updates will be listed below